Skip to content

Trial Comparing hCG Triggering Versus GnRH Agonist Triggering in PCOS Patients

Prospective Randomized Trial on GnRH Agonist Triggering Versus hCG Triggering in IVF Stimulation in PCOS Patients

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01683513
Enrollment
120
Registered
2012-09-12
Start date
2011-11-30
Completion date
2015-02-28
Last updated
2021-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility, PCOS

Keywords

OHSS, mataphase II oocytes (MII), good quality embryo's, pregnancy

Brief summary

In this study the investigators compare the traditional way of triggering with a new way in patients with Poly Cystic Ovary Syndrome (PCOS). This to reduce the risque of Ovary Hyper Stimulation Syndrome (OHSS) in In Vitro Fertilization/ IntraCytoplastic Sperm Injection (IVF/ ICSI) treatment. The investigators also compare the number of mature oocytes, embryo's and pregnancy rate.

Interventions

DRUGGnRh agonist +1500E hCG

ovulation induction with GnRh agonist and 1500E hCG one hour after egg retrieval

Sponsors

Onze Lieve Vrouw Hospital
CollaboratorOTHER
AZ Jan Palfijn Gent
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 38 Years
Healthy volunteers
No

Inclusion criteria

* ICSI patients below 38 years * 1, 2 and 3e IVF cycle * Body Mass Index (BMI) less than 32 * PCOS patients

Exclusion criteria

* endocrinal diseases or problems

Design outcomes

Primary

MeasureTime frameDescription
MII oocytespatients will be followed during the stimulation with an average of 10 daysThe number of mature oocytes retrieved after stimulation without creating OHSS
2 Pro Nuclei (2PN) fertilization24h after ICSIlaboratory follow up of the fertilized egg during the first 24h

Secondary

MeasureTime frameDescription
implantation rate12 weeksThe number of pregnancies obtained wich still is the most important issue for the patients
OHSSone month with oocyte retrieval in the middlepatient follow up according to subjective complaints and objective measures

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026